Jun 9, 2020Paper

Favipiravir strikes the SARS-CoV-2 at its Achilles heel, the RNA polymerase

BioRxiv : the Preprint Server for Biology
Ashleigh ShannonBruno Canard

Abstract

The ongoing Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has emphasized the urgent need for antiviral therapeutics. The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases. Here we show that Favipiravir exerts an antiviral effect as a nucleotide analogue through a combination of chain termination, slowed RNA synthesis and lethal mutagenesis. The SARS-CoV RdRp complex is at least 10-fold more active than any other viral RdRp known. It possesses both unusually high nucleotide incorporation rates and high-error rates allowing facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome. The coronavirus RdRp complex represents an Achilles heel for SARS-CoV, supporting nucleoside analogues as promising candidates for the treatment of COVID-19.

Citations

Aug 12, 2020·Reviews in Medical Virology·Coralie ValleEtienne Decroly
Sep 10, 2020·International Journal of Molecular Sciences·Neelu BatraAi-Ming Yu
Oct 11, 2020·Proceedings of the National Academy of Sciences of the United States of America·Suzanne J F KapteinLeen Delang
Dec 30, 2020·Expert Review of Anti-infective Therapy·Seyed MohammadReza HashemianAli Akbar Velayati
Jan 27, 2021·Infectious Diseases and Therapy·Nicholas ReboldMichael Rybak
Dec 9, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Francesca PicarazziMattia Mori
Oct 30, 2020·Nature Reviews. Microbiology·Philip V'kovskiVolker Thiel
Mar 19, 2021·International Immunopharmacology·Masoud Solaymani-DodaranJavad Moazen
Mar 23, 2021·Frontiers in Microbiology·Ahmad F EweasAhmed S Abdel-Moneim
Mar 26, 2021·Frontiers in Molecular Biosciences·Karthik VivekanandhanMuthupandian Saravanan
May 1, 2021·Viruses·Robert J GeraghtyLaurent F Bonnac
Jun 15, 2021·Curēus·Dhigishaba M Jadeja, Nirmit R Patel
Jul 5, 2021·International Immunopharmacology·Seyed MohammadReza HashemianAli Akbar Velayati

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioRxiv & MedRxiv Preprints

BioRxiv and MedRxiv are the preprint servers for biology and health sciences respectively, operated by Cold Spring Harbor Laboratory. Here are the latest preprint articles (which are not peer-reviewed) from BioRxiv and MedRxiv.